{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:02:25Z","timestamp":1789588945634,"version":"build-2803163510"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"DOI":"10.7759\/cureus.116368","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:06:51Z","timestamp":1789585611000},"source":"Crossref","is-referenced-by-count":0,"title":["Antipsychotic-Induced Parkinsonism With Concurrent Benztropine-Associated Anticholinergic Effects in a Community Emergency Department Setting: A Case Report"],"prefix":"10.7759","author":[{"given":"Colin","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Sreedharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257129","article-title":"Antipsychotic-induced extrapyramidal side effects: a systematic review and meta-analysis of observational studies","volume":"16","author":"Ali T","year":"2021","unstructured":"Ali T, Sisay M, Tariku M, Mekuria AN, Desalew A. Antipsychotic-induced extrapyramidal side effects: a systematic review and meta-analysis of observational studies. PLoS One. 2021, 16:e0257129. 10.1371\/journal.pone.0257129","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S360268","article-title":"Updated perspectives on the management of drug-induced parkinsonism (DIP): insights from the clinic","volume":"18","author":"Feldman M","year":"2022","unstructured":"Feldman M, Marmol S, Margolesky J. Updated perspectives on the management of drug-induced parkinsonism (DIP): insights from the clinic. Ther Clin Risk Manag. 2022, 18:1129-42. 10.2147\/TCRM.S360268","journal-title":"Ther Clin Risk Manag"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001061","article-title":"Characteristics of patients experiencing extrapyramidal symptoms or other movement disorders related to dopamine receptor blocking agent therapy","volume":"39","author":"Musco S","year":"2019","unstructured":"Musco S, Ruekert L, Myers J, Anderson D, Welling M, Cunningham EA. Characteristics of patients experiencing extrapyramidal symptoms or other movement disorders related to dopamine receptor blocking agent therapy. J Clin Psychopharmacol. 2019, 39:336-43. 10.1097\/JCP.0000000000001061","journal-title":"J Clin Psychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/656370","article-title":"Second-generation antipsychotics and extrapyramidal adverse effects","volume":"2014","author":"Divac N","year":"2014","unstructured":"Divac N, Prostran M, Jakovcevski I, Cerovac N. Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int. 2014, 2014:656370. 10.1155\/2014\/656370","journal-title":"Biomed Res Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S176478","article-title":"Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia","volume":"14","author":"Takada R","year":"2018","unstructured":"Takada R, Yamamuro K, Kishimoto T. Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia. Neuropsychiatr Dis Treat. 2018, 14:2541-4. 10.2147\/NDT.S176478","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01078-z","article-title":"An evidence-based update on anticholinergic use for drug-induced movement disorders","volume":"38","author":"Vanegas-Arroyave N","year":"2024","unstructured":"Vanegas-Arroyave N, Caroff SN, Citrome L, et al.. An evidence-based update on anticholinergic use for drug-induced movement disorders. CNS Drugs. 2024, 38:239-54. 10.1007\/s40263-024-01078-z","journal-title":"CNS Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-021-02306-2","article-title":"Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials","volume":"128","author":"Danysz W","year":"2021","unstructured":"Danysz W, Dekundy A, Scheschonka A, Riederer P. Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials. J Neural Transm (Vienna). 2021, 128:127-69. 10.1007\/s00702-021-02306-2","journal-title":"J Neural Transm (Vienna)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-014-0078-0","article-title":"Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis","volume":"15","author":"Belvederi Murri M","year":"2015","unstructured":"Belvederi Murri M, Guaglianone A, Bugliani M, et al.. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D. 2015, 15:45-62. 10.1007\/s40268-014-0078-0","journal-title":"Drugs R D"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/JPRLS.S99197","article-title":"Drug-induced parkinsonism: diagnosis and management","volume":"6","author":"Blanchet P","year":"2016","unstructured":"Blanchet P, Kivenko V. Drug-induced parkinsonism: diagnosis and management. Res Rev Parkinsonism. 2016, 6:83-91. 10.2147\/JPRLS.S99197","journal-title":"Res Rev Parkinsonism"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506850-antipsychotic-induced-parkinsonism-with-concurrent-benztropine-associated-anticholinergic-effects-in-a-community-emergency-department-setting-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:06:51Z","timestamp":1789585611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506850-antipsychotic-induced-parkinsonism-with-concurrent-benztropine-associated-anticholinergic-effects-in-a-community-emergency-department-setting-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.116368","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}